Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 91.10
+4.90 (5.68%)
Oct 21, 2026, 10:08 AM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 6.09 billion as of October 20, 2026. It is the 21,496th most valuable company in the world and the 1,014th biggest in Taiwan. Its market cap has decreased by 68.59% in one year.
Market Cap
6.09B
Enterprise Value
3.80B
Revenue
3.00M
Global Rank
Country Rank
#1,014 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 6.09B, an increase of 137.25%. That is a compound annual growth rate of 15.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 6.09B | -70.03% |
| Dec 31, 2025 | 20.31B | 114.84% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.23B |
| Standard Chemical & Pharmaceutical | 10.35B |
| SCI Pharmtech | 6.39B |
| Orient Pharma | 5.89B |
| Formosa Laboratories | 5.80B |
| Yoda Pharmaceuticals | 5.06B |
| Panion & Bf Biotech | 4.64B |
| LIWANLI Innovation | 4.57B |